Tracey Seipel CEO at Seipel Group formulator of Award winning Urox bladder control wins Women in International business export award for Queensland premier export awards Trade investment Queensland.
Up against some strong competition Tracey said “this is a win for all Australian Women CEO.It has been a long road that continues to challenge us.”
The Urox bladder Control product has undergone over 25 years of research and development. 14 Clinical trials an international mechanism of action study confirming its effectiveness in reducing incontinence and allows the bladder to empty and fill properly building compliance and bladder strength. Urox Bladder Control, Prorox prostate and bladder control is changing lives and giving many people back their freedom.
Exporting now to over ten countries and being private labelled in the USA market by some of the biggest companies in complementary medicine market we are proud of what we have achieved.One of the key areas now to conquer is Aged Care with other countries looking at Urox to form part of a strategy to minimise recurrent UTI preventing falls due to confusion that often occurs with the infection.
Urox was found effective to reduce pad usage this also addresses the land fill issues, costs of disposal and cleaning. By 2029, globally, sales of Urox will be preventing up to 960,000 tonnes greenhouse gas emissions.
